A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients

Authors
Publication date
1 January 2004
Publisher
ACTA MEDICAL BELGICA

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ghent University Academic Bibliography

    redirect
    oaioai:archive.ugent.be:306058
    Last time updated on 12/11/2016